Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01589341 · ClinicalTrials.gov registry record

Studying Chromosomes in Samples From Younger Patients With Neuroblastoma

A clinical trial, sponsored by Children's Oncology Group.

Completed
Registry status
300
Enrollment target

NCT01589341 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 300 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01589341 has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
300 participants
Enrollment target

Study Summary

This research studies chromosomes in samples from younger patients with neuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

Interventions

  • OTHER laboratory biomarker analysis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2012-04

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT01589341

The ClinicalTrials.gov registry entry for NCT01589341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.

NCT01589341 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01589341 about?

NCT01589341 is a clinical study titled "Studying Chromosomes in Samples From Younger Patients With Neuroblastoma". This research studies chromosomes in samples from younger patients with neuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

What is the current status of trial NCT01589341?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2012-04.

What interventions are being tested in trial NCT01589341?

The interventions under investigation include: laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT01589341?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.